Worldwide Clinical Trials

NOVEMBER 3, 2022

BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinical research. In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinical trials. Looking to diversify the reach of your orphan drug trial?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Drugs 130

pharmaphorum

OCTOBER 27, 2020

Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments. In trials for cardiovascular, HIV, kidney disease and digestive diseases, women have especially been underrepresented.

Clinical Trials 115

Clinical Trials Clinical Trials Trials Development 115

VirTrial

MAY 26, 2020

Virtual Pre-Site includes delivery of HD live-streaming glasses that enable an on-site Clinical Research Coordinator (CRC) to provide a remote Clinical Research Associate (CRA) access to all aspects of the site virtually simply by walking through the site wearing the glasses.

Research 71

Research Clinical Trials Clinical Trials Clinical Research Coordinator 71

XTalks

AUGUST 4, 2022

The US Food and Drug Administration (FDA) is emphasizing the need for diversity in clinical trials. This started back in 1993 when the FDA established guidelines to increase diversity by gender and race/ethnicity of participants in clinical trials that were contributing to new drug approvals.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

JULY 29, 2021

Just as clinical researchers in other therapeutic areas have renewed their commitment to improving participant diversity in clinical trials, so too have those working in Alzheimer’s research. What Factors Promote Alzheimer’s Clinical Trial Participation?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Research 98

Drug Discovery World

FEBRUARY 20, 2023

Breast cancer retained its position as the most-studied disease area in clinical trials in 2022, according to a recent report by analytics company Phesi. Here, we take a look at the top four disease areas and some of the key developments in 2022. Capivasertib could offer a completely new treatment option for these patients.

Drug Trials 52

Drug Trials Trials Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 10, 2020

Biomarkers will be critical to developing precision medicine for Alzheimer’s disease. Although a few are out there, phosphorylated tau (P-tau) may enable even earlier and more accurate detection, according to Eli Lilly-associated researchers speaking at the Clinical Trials on Alzheimer’s Disease (CTAD) virtual conference in early November.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Antibody 52

pharmaphorum

JANUARY 19, 2021

A survey of members of the Raremark community found that 86% of respondents were interested in taking part in a clinical trial now or in the future. Research and development will always be important to rare disease patients. A few others said they would struggle to comprehend all the trial literature on their own.

Trials 114

Trials Research Clinical Trials Clinical Trials 114

Delveinsight

AUGUST 13, 2021

Clinical trials are an essential part of the drug development process. Worldwide, more than 2 million clinical trials are registered and the number is steadily increasing over the past several years. The conduct of trials was not possible due to the risk of catching coronavirus. Why the Need?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Drugs 98